Mallal SA - Search Results

1

Pharmacogenetics of drug hypersensitivity.

Phillips EJ, Mallal SA. Phillips EJ, et al. Among authors: mallal sa. Pharmacogenomics. 2010 Jul;11(7):973-87. doi: 10.2217/pgs.10.77. Pharmacogenomics. 2010. PMID: 20602616 Free PMC article. Review.

2

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT. Mallal S, et al. Lancet. 2002 Mar 2;359(9308):727-32. doi: 10.1016/s0140-6736(02)07873-x. Lancet. 2002. PMID: 11888582

3

Pharmacogenetics: a practical role in predicting antiretroviral drug toxicity?

Nolan D, Gaudieri S, Mallal S. Nolan D, et al. J HIV Ther. 2003 May;8(2):36-41. J HIV Ther. 2003. PMID: 12838163 Review.

4

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.

Martin AM, Nolan D, Gaudieri S, Almeida CA, Nolan R, James I, Carvalho F, Phillips E, Christiansen FT, Purcell AW, McCluskey J, Mallal S. Martin AM, et al. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4180-5. doi: 10.1073/pnas.0307067101. Epub 2004 Mar 15. Proc Natl Acad Sci U S A. 2004. PMID: 15024131 Free PMC article.

5

Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity.

Martin AM, Nolan D, Gaudieri S, Phillips E, Mallal S. Martin AM, et al. Pharmacogenomics. 2004 Sep;5(6):643-55. doi: 10.1517/14622416.5.6.643. Pharmacogenomics. 2004. PMID: 15335286 Review.

6

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.

Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, Phillips E, Christiansen FT, Mallal S. Martin AM, et al. AIDS. 2005 Jan 3;19(1):97-9. doi: 10.1097/00002030-200501030-00014. AIDS. 2005. PMID: 15627041

7

Clinical and immunogenetic correlates of abacavir hypersensitivity.

Phillips EJ, Wong GA, Kaul R, Shahabi K, Nolan DA, Knowles SR, Martin AM, Mallal SA, Shear NH. Phillips EJ, et al. Among authors: mallal sa. AIDS. 2005 Jun 10;19(9):979-81. doi: 10.1097/01.aids.0000171414.99409.fb. AIDS. 2005. PMID: 15905681

8

Predicting and diagnosing abacavir and nevirapine drug hypersensitivity: from bedside to bench and back again.

Martin A, Nolan D, Almeida CA, Rauch A, Mallal S. Martin A, et al. Pharmacogenomics. 2006 Jan;7(1):15-23. doi: 10.2217/14622416.7.1.15. Pharmacogenomics. 2006. PMID: 16354121 Review.

9

Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance.

Nolan D, Phillips E, Mallal S. Nolan D, et al. Clin Infect Dis. 2006 Feb 1;42(3):408-10. doi: 10.1086/499369. Epub 2005 Dec 27. Clin Infect Dis. 2006. PMID: 16392090 No abstract available.

10

A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome.

Martin AM, Krueger R, Almeida CA, Nolan D, Phillips E, Mallal S. Martin AM, et al. Pharmacogenet Genomics. 2006 May;16(5):353-7. doi: 10.1097/01.fpc.0000197468.16126.cd. Pharmacogenet Genomics. 2006. PMID: 16609367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page